Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$595,806
in 1 filing, $596K under 10b5-1 plans

Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Heffernan Michael Thomas −$596K Director sold 86% of stake

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-29 SCIASCIA THOMAS Chief Scientific Officer Sale −53,368 $2.55 $136K 214,433
2024-05-29 SCIASCIA THOMAS Chief Scientific Officer Option exercise · Stock Option (right to buy) −59,354 0
2024-02-15 SCIASCIA THOMAS Chief Scientific Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2023-02-16 SCIASCIA THOMAS Chief Scientific Officer Grant or award · Stock Option (right to buy) +187,500 187,500
2022-09-19 SCIASCIA THOMAS Chief Medical Officer Grant or award · Performance Stock Options (right to buy) +7,500 37,500
2022-06-29 SCIASCIA THOMAS Chief Medical Officer Grant or award · Performance Stock Options (right to buy) +30,000 30,000
2022-02-11 SCIASCIA THOMAS Chief Medical Officer Grant or award · Stock Option (right to buy) +110,000 110,000
2022-02-11 SCIASCIA THOMAS Chief Medical Officer Grant or award · Stock Option (right to buy) +110,000 110,000
2021-02-17 SCIASCIA THOMAS Chief Medical Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2020-02-13 SCIASCIA THOMAS Chief Medical Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2019-06-03 SCIASCIA THOMAS Chief Medical Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2019-05-09 SCIASCIA THOMAS Chief Medical Officer Conversion +17,118 193,724
2019-05-09 SCIASCIA THOMAS Chief Medical Officer Conversion · Series A Preferred Stock −109,015 0
2019-05-09 SCIASCIA THOMAS Chief Medical Officer Conversion · Series C Preferred Stock −13,410 0

Page 2 of 2 · 34 trades